Filters

Clear all

Expert Opinion

Plain Language Summary

Expert Review

Text Availability

Abstract

Full text

Free full text

Publication Types

Journal Article

Research Support, Non-U.S. Gov't

Review

Research Support, U.S. Gov't, P.H.S.

Clinical Trial

Comparative Study

Clinical Trial, Phase II

Randomized Controlled Trial

Multicenter Study

Publication Year

From

Quick links

Individual year

2021

2006

2005

2003

2002

2001

Sort by:

selected

Print page

Email selected articles

Favourite selected articles

Create a NED Search Alert for this search

Save this search

Advanced Search

Run an advanced search

Results for
""Myelin Proteins""[mesh_terms]

11 Results

Searching titles within these results

Specificity of autoantibodies to epitopes of myelin proteins in multiple sclerosis.

Permphan Dharmasaroja

Journal of the neurological sciences 2003;206(1):7-16

Full Text

Abstract

Pharmacogenetic interactions in amyotrophic lateral sclerosis: a step closer to a cure?

Ruben P A van Eijk, Marinus J C Eijkemans, Stavros Nikolakopoulos, Marc D Jansen, Henk-Jan Westeneng, Kristel R van Eijk, Rick A A van der Spek, Joke J F A van Vugt, Sanne Piepers, Geert-Jan Groeneveld, Jan H Veldink, Leonard H van den Berg, Michael A van Es

The pharmacogenomics journal 2021;20(2):220-226

Full Text

Abstract

Mutations of peripheral myelin protein 22 result in defective trafficking through mechanisms which may be common to diseases involving tetraspan membrane proteins.

M W McEnery, F Ismail-Beigi, C R Sanders

Biochemistry 2001;40(32):9453-9

Full Text

Abstract

Evidence of nitrosative damage in the brain white matter of patients with multiple sclerosis.

Oscar A Bizzozero, Gisela DeJesus, Heather A Bixler, Andrzej Pastuszyn

Neurochemical research 2005;30(1):139-49

Full Text

Abstract

Structure and function of the myelin proteins: current status and perspectives in relation to multiple sclerosis.

Andreas G Tzakos, Anastassios Troganis, Vassiliki Theodorou, Theodore Tselios, Christos Svarnas, John Matsoukas, Vasso Apostolopoulos, Ioannis P Gerothanassis

Current medicinal chemistry 2005;12(13):1569-87

Full Text

Abstract

The fine specificity of the myelin oligodendrocyte glycoprotein autoantibody response in patients with multiple sclerosis and normal healthy controls.

C G Haase, J Guggenmos, U Brehm, M Andersson, T Olsson, M Reindl, J M Schneidewind, U K Zettl, F Heidenreich, T Berger, H Wekerle, R Hohlfeld, C Linington

Journal of neuroimmunology 2001;114(1-2):220-5

Full Text

Abstract

Epitope specificity of serum antibodies directed against the extracellular domain of myelin oligodendrocyte glycoprotein: Influence of relapses and immunomodulatory treatments.

Michael Khalil, Markus Reindl, Andreas Lutterotti, Bettina Kuenz, Rainer Ehling, Claudia Gneiss, Peter Lackner, Florian Deisenhammer, Thomas Berger

Journal of neuroimmunology 2006;174(1-2):147-56

Full Text

Abstract

Depletion of Vbeta5.2/5.3 T cells with a humanized antibody in patients with multiple sclerosis.

Tomas Olsson, C Edenius, M Ferm, P Samuelson, A Torrång, E Wallström, M Khademi, M Andersson, L Arfors

European journal of neurology 2002;9(2):153-64

Full Text

Abstract

Antibody cross-linking of myelin oligodendrocyte glycoprotein leads to its rapid repartitioning into detergent-insoluble fractions, and altered protein phosphorylation and cell morphology.

C B Marta, C M Taylor, T Coetzee, T Kim, S Winkler, R Bansal, S E Pfeiffer

The Journal of neuroscience : the official journal of the Society for Neuroscience 2003;23(13):5461-71

Free Full Text

Abstract

T cells, cytokines, and autoantigens in multiple sclerosis.

A Rostami, B Gran

Current neurology and neuroscience reports 2002;1(3):263-70

Full Text

Abstract

Antibody-mediated suppression of Vbeta5.2/5.3(+) T cells in multiple sclerosis: results from an MRI-monitored phase II clinical trial.

Joep Killestein, Tomas Olsson, Erik Wallström, Anders Svenningsson, Mohsen Khademi, Lance D Blumhardt, Jan Fagius, Jan Hillert, Anne-Marie Landtblom, Charlotte Edenius, Leopold Arfors, Frederik Barkhof, Chris H Polman

Annals of neurology 2002;51(4):467-74

Full Text

Abstract

Results: 1 – 11 / 11

Filters

Expert Opinion

Text Availability

Publication Types

Publication Year

Results for ""Myelin Proteins""[mesh_terms]

Specificity of autoantibodies to epitopes of myelin proteins in multiple sclerosis.

Pharmacogenetic interactions in amyotrophic lateral sclerosis: a step closer to a cure?

Mutations of peripheral myelin protein 22 result in defective trafficking through mechanisms which may be common to diseases involving tetraspan membrane proteins.

Evidence of nitrosative damage in the brain white matter of patients with multiple sclerosis.

Structure and function of the myelin proteins: current status and perspectives in relation to multiple sclerosis.

The fine specificity of the myelin oligodendrocyte glycoprotein autoantibody response in patients with multiple sclerosis and normal healthy controls.

Epitope specificity of serum antibodies directed against the extracellular domain of myelin oligodendrocyte glycoprotein: Influence of relapses and immunomodulatory treatments.

Depletion of Vbeta5.2/5.3 T cells with a humanized antibody in patients with multiple sclerosis.

Antibody cross-linking of myelin oligodendrocyte glycoprotein leads to its rapid repartitioning into detergent-insoluble fractions, and altered protein phosphorylation and cell morphology.

T cells, cytokines, and autoantigens in multiple sclerosis.

Antibody-mediated suppression of Vbeta5.2/5.3(+) T cells in multiple sclerosis: results from an MRI-monitored phase II clinical trial.

Results for
""Myelin Proteins""[mesh_terms]